According to Lannett Company's latest financial reports the company's total debt is $0.63 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-06-30 | $0.62 B | 3.85% |
2021-06-30 | $0.60 B | -12.76% |
2020-06-30 | $0.69 B | -5.07% |
2019-06-30 | $0.72 B | -13.13% |
2018-06-30 | $0.83 B | -7.12% |
2017-06-30 | $0.90 B | -14.9% |
2016-06-30 | $1.06 B | 105137.66% |
2015-06-30 | $1 M | -11.34% |
2014-06-30 | $1.13 M | -82.53% |
2013-06-30 | $6.51 M | -9.04% |
2012-06-30 | $7.16 M | -8.45% |
2011-06-30 | $7.82 M | 1.32% |
2010-06-30 | $7.71 M | -5.15% |
2009-06-30 | $8.13 M | -9.36% |
2008-06-30 | $8.97 M | -7.24% |
2007-06-30 | $9.67 M | 18.1% |
2006-06-30 | $8.19 M | -14.01% |
2005-06-30 | $9.53 M | -5.55% |
2004-06-30 | $10.09 M | 225.81% |
2003-06-30 | $3.09 M | -25.22% |
2002-06-30 | $4.14 M | -61.55% |
2001-06-30 | $10.77 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $33.63 B | 5,158.06% | ๐บ๐ธ USA |
Novartis NVS | $27.28 B | 4,165.60% | ๐จ๐ญ Switzerland |
Pfizer PFE | $70.84 B | 10,975.97% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $15.62 B | 2,343.30% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $22.45 B | 3,411.26% | ๐ฌ๐ง UK |